New Delhi: Another vaccine has now been included in India’s vaccination against the corona epidemic. American company Moderna’s vaccine has been approved for emergency use in our country. With this, Moderna’s vaccine has become the fourth one to be used in India after Covishield, Covaccine and Sputnik V. The Drug Controller General of India (DCGI) has given its nod to Cipla for the import of Moderna vaccine. But in the meantime, a question arises that how did Moderna’s vaccine get approval for use without any prior trial in the country. Let us tell you why this happened?
Why no trial was needed?
Actually, the Moderna vaccine has already been included in the World Health Organization’s (WHO) list, hence, it was considered that no trial is compulsory for its use in India.
The temperature suggested for Moderna vaccine?
In a temperature between -25 to -50 degree, the Moderna vaccine can be kept safe for seven months. Generally, the modern vaccine needs a temperature around -20 degrees. If the vial is not open, then it can be kept in two to eight degree temperature for 30 days. It is necessary to take two doses between four weeks.
The first consignment to arrive in July
The first consignment of Moderna Vaccine is expected to arrive in India in July. Thereafter, the testing of the first batch will be done in the Central Laboratory located in Kasauli. Initially, only 100 people will be given this jab and after a thorough study the Moderan vaccine will be available in the hospitals. The whole process may take a month.
The vaccines so far approved for use in India
Covishield of Serum Institute of India was the first vaccine to get emergency clearance in January 2021
The second one was Bharat Biotech’s Covaccine which also got approved in January 2021
Sputnik was the third vaccine to get clearance in India for use in April 2021
Latest and the fourth one is Moderna’s vaccine which got approval in June 2021